These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Making sense of risk diagnosis in case of prenatal and reproductive genetic counselling for neuromuscular diseases. Zaccaro A; Freda MF J Health Psychol; 2014 Mar; 19(3):344-57. PubMed ID: 23407130 [TBL] [Abstract][Full Text] [Related]
28. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044 [TBL] [Abstract][Full Text] [Related]
29. Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. McAllister M Clin Genet; 2003 Sep; 64(3):179-89. PubMed ID: 12919131 [TBL] [Abstract][Full Text] [Related]
30. Life and health insurance behaviour of individuals having undergone a predictive genetic testing programme for hereditary non-polyposis colorectal cancer. Aktan-Collan K; Haukkala A; Kaariainen H Community Genet; 2001; 4(4):219-24. PubMed ID: 12751485 [TBL] [Abstract][Full Text] [Related]
31. Genetic counselling in parents of children with congenital heart disease significantly improves knowledge about causation and enhances psychosocial functioning. Blue GM; Kasparian NA; Sholler GF; Kirk EP; Winlaw DS Int J Cardiol; 2015 Jan; 178():124-30. PubMed ID: 25464235 [TBL] [Abstract][Full Text] [Related]
33. Economic evaluation of the familial cancer programme in Western Australia: predictive genetic testing for familial adenomatous polyposis and hereditary non-polyposis colorectal carcinoma. Breheny N; Geelhoed E; Goldblatt J; Ee H; O'Leary P Community Genet; 2006; 9(2):98-106. PubMed ID: 16612060 [TBL] [Abstract][Full Text] [Related]
34. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling. Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645 [TBL] [Abstract][Full Text] [Related]
35. Hereditary non-polyposis colorectal cancer: an updated review. Anwar S; Hall C; White J; Deakin M; Farrell W; Elder JB Eur J Surg Oncol; 2000 Nov; 26(7):635-45. PubMed ID: 11078609 [TBL] [Abstract][Full Text] [Related]
38. Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome. Bruwer Z; Futter M; Ramesar R Patient Educ Couns; 2013 Jul; 92(1):53-60. PubMed ID: 23453851 [TBL] [Abstract][Full Text] [Related]
39. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community. Schofield L; Goldblatt J; Iacopetta B Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021 [TBL] [Abstract][Full Text] [Related]
40. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Rouprêt M; Yates DR; Comperat E; Cussenot O Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]